{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T02:30:48Z","timestamp":1786933848267,"version":"build-2736575974"},"reference-count":24,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","redjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.ijrobp.2025.02.012","type":"journal-article","created":{"date-parts":[[2025,2,22]],"date-time":"2025-02-22T06:55:36Z","timestamp":1740207336000},"page":"1158-1165","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Preoperative Single Fraction Stereotactic Partial Breast Irradiation for Early-Stage Breast Cancer Patients With GammaPod Technology: Pathologic Findings and Ki-67 Evaluation"],"prefix":"10.1016","volume":"122","author":[{"given":"Chiara","family":"Reverberi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Facondo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnese","family":"Prisco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tino","family":"Ceschia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugenia","family":"Moretti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Scalchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrico","family":"Pegolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Orsaria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Zuiani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Seriau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serena","family":"Bertozzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yvonne","family":"Beorchia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi","family":"Castriotta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla","family":"Cedolini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla Di","family":"Loreto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Trov\u00f2","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2025.02.012_bib0001","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.prro.2016.09.007","article-title":"Accelerated partial breast irradiation: Executive summary for the update of an ASTRO evidence-based consensus statement","volume":"7","author":"Correa","year":"2017","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2025.02.012_bib0002","first-page":"94","article-title":"Preoperative robotic radiosurgery for early breast cancer: Results of the phase II ROCK trial (NCT03520894)","volume":"37","author":"Meattini","year":"2022","journal-title":"Clin Transl Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2025.02.012_bib0003","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/S0140-6736(17)31145-5","article-title":"Partial-breast radiotherapy after breast conservation surgery for patients with early breast cancer (UK IMPORT LOW trial): 5-year results from a multicentre, randomised, controlled, phase 3, non-inferiority trial","volume":"390","author":"Coles","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.ijrobp.2025.02.012_bib0004","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1016\/S0140-6736(19)32515-2","article-title":"External beam accelerated partial breast irradiation versus whole breast irradiation after breast conserving surgery in women with ductal carcinoma in situ and node-negative breast cancer (RAPID): A randomised controlled trial","volume":"394","author":"Whelan","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.ijrobp.2025.02.012_bib0005","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1016\/S0140-6736(19)32514-0","article-title":"Long-term primary results of accelerated partial breast irradiation after breast-conserving surgery for early-stage breast cancer: A randomised, phase 3, equivalence trial","volume":"394","author":"Vicini","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.ijrobp.2025.02.012_bib0006","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.critrevonc.2019.06.003","article-title":"Preoperative radiotherapy: A paradigm shift in the treatment of breast cancer? A review of literature","volume":"141","author":"Corradini","year":"2019","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.ijrobp.2025.02.012_bib0007","doi-asserted-by":"crossref","DOI":"10.1118\/1.4798961","article-title":"GammaPod-a new device dedicated for stereotactic radiotherapy of breast cancer","volume":"40","author":"Yu","year":"2013","journal-title":"Med Phys"},{"key":"10.1016\/j.ijrobp.2025.02.012_bib0008","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1111\/j.1365-2559.2006.02419.x","article-title":"Laboratory handling and histology reporting of breast specimens from patients who have received neoadjuvant chemotherapy","volume":"50","author":"Pinder","year":"2007","journal-title":"Histopathology"},{"key":"10.1016\/j.ijrobp.2025.02.012_bib24","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.4049\/jimmunol.133.4.1710","article-title":"Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67","volume":"133","author":"Gerdes","year":"1984","journal-title":"J Immunol"},{"key":"10.1016\/j.ijrobp.2025.02.012_bib0009","doi-asserted-by":"crossref","first-page":"7212","DOI":"10.1200\/JCO.2005.07.501","article-title":"Proliferation marker Ki-67 in early breast cancer","volume":"23","author":"Urruticoechea","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2025.02.012_bib0010","first-page":"213","article-title":"The proper Ki-67 cut-off in hormone responsive breast cancer: A monoinstitutional analysis with long-term follow-up","volume":"13","author":"Lombardi","year":"2021","journal-title":"Breast Cancer (Dove Med Press)"},{"key":"10.1016\/j.ijrobp.2025.02.012_bib0011","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1016\/j.ijrobp.2004.05.072","article-title":"Biologic comparison of partial breast irradiation protocols","volume":"60","author":"Rosenstein","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2025.02.012_bib0012","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1016\/j.ijrobp.2015.03.007","article-title":"Preoperative single-fraction partial breast radiation therapy: A novel phase 1, dose-escalation protocol with radiation response biomarkers","volume":"92","author":"Horton","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2025.02.012_bib0021","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1186\/s12885-023-10910-6","article-title":"Prediction of pathologic complete response after single-dose MR-guided partial breast irradiation in low-risk breast cancer patients: The ABLATIVE-2 trial-a study protocol","volume":"23","author":"Civil","year":"2023","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ijrobp.2025.02.012_bib0013","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.ijrobp.2016.11.030","article-title":"Preoperative accelerated partial breast irradiation for early-stage breast cancer: Preliminary results of a prospective, phase 2 trial","volume":"97","author":"Nichols","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2025.02.012_bib0014","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/j.ijrobp.2019.12.037","article-title":"Five-year results of the preoperative accelerated partial breast irradiation (PAPBI) trial","volume":"106","author":"Bosma","year":"2020","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2025.02.012_bib0015","doi-asserted-by":"crossref","first-page":"e334","DOI":"10.3747\/co.26.4479","article-title":"Stereotactic image-guided neoadjuvant ablative single-dose radiation, then lumpectomy, for early breast cancer: The SIGNAL prospective single-arm trial of single-dose radiation therapy","volume":"26","author":"Guidolin","year":"2019","journal-title":"Curr Oncol"},{"key":"10.1016\/j.ijrobp.2025.02.012_bib0016","doi-asserted-by":"crossref","first-page":"155","DOI":"10.3747\/co.27.6059","article-title":"Tumour response 3 months after neoadjuvant single-fraction radiotherapy for low-risk breast cancer","volume":"27","author":"Tiberi","year":"2020","journal-title":"Curr Oncol"},{"key":"10.1016\/j.ijrobp.2025.02.012_bib0017","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.ijrobp.2022.12.036","article-title":"Phase 2 study of preoperative SABR for early-stage breast cancer: Introduction of a novel form of accelerated partial breast radiation therapy","volume":"116","author":"Liveringhouse","year":"2023","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2025.02.012_bib0018","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.ijrobp.2019.11.406","article-title":"Tumor response after neoadjuvant magnetic resonance guided single ablative dose partial breast irradiation","volume":"106","author":"Vasmel","year":"2020","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2025.02.012_bib0019","doi-asserted-by":"crossref","first-page":"e7","DOI":"10.1016\/j.ijrobp.2023.08.035","article-title":"Early results of a phase I pre-operative single fraction ablative trial for early stage breast cancer","volume":"117","author":"Rahimi","year":"2023","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2025.02.012_bib0020","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1186\/s12885-022-09305-w","article-title":"Single fraction ablative preoperative radiation treatment for early-stage breast cancer: The CRYSTAL study - A phase I\/II clinical trial protocol","volume":"22","author":"Zerella","year":"2022","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ijrobp.2025.02.012_bib0022","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1001\/jamaoncol.2018.6993","article-title":"Measuring the integration of stereotactic ablative radiotherapy plus surgery for early-stage non-small cell lung cancer: A phase 2 clinical trial","volume":"5","author":"Palma","year":"2019","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.ijrobp.2025.02.012_bib0023","doi-asserted-by":"crossref","first-page":"551","DOI":"10.3389\/fonc.2019.00551","article-title":"Does pathologic response equate to clinical response following SABR for early-stage NSCLC?","volume":"9","author":"Brooks","year":"2019","journal-title":"Front Oncol"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S036030162500152X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S036030162500152X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,16]],"date-time":"2025-07-16T05:24:42Z","timestamp":1752643482000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S036030162500152X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":24,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["S036030162500152X"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2025.02.012","relation":{},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Preoperative Single Fraction Stereotactic Partial Breast Irradiation for Early-Stage Breast Cancer Patients With GammaPod Technology: Pathologic Findings and Ki-67 Evaluation","name":"articletitle","label":"Article Title"},{"value":"International Journal of Radiation Oncology*Biology*Physics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijrobp.2025.02.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}